Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy

Journal of Clinical Pathology

Volumn 67, Issue 8, 2014, Pages 678-683

  Schneider, Frank ^a   Yousem, Samuel A ^a   Bi, David ^a   Gibson, Kevin F ^b   Oddis, Chester V ^b   Aggarwal, Rohit ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FIBROSIS; INFLAMMATION; LUNG; MUSCLE;

ADULT; AGED; AUTOANTIBODIES; FEMALE; GLYCINE-TRNA LIGASE; HUMANS; LUNG; MALE; MIDDLE AGED; MYOSITIS;

EID: 84905113380     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202367     Document Type: Article

References (25)

1. Takahashi T, Wada I, Ohtsuka Y, et al. Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis. Respirology 2007;12:642-53. (Pubitemid 47414894)
2. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459-67. (Pubitemid 26274719)
3. Aggarwal R, Cassidy E, Fertig N, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 2014;73:227-32.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
5. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
6. Travis WD, Costabel U, Hansell DM, et al. An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48.
7. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006;39:233-41. (Pubitemid 43879036)
8. Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE 2013;8:e60442.
9. Targoff IN, Trieu EP, Plotz PH, et al. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992;35:821-30.
10. Takato H, Waseda Y, Watanabe S, et al . Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia - with or without PM/DM. Respir Med 2013;107:128-33.
11. Douglas W, Tazelaar H, Hartman T, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-5. (Pubitemid 33052247)
12. Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006;130:553-8. (Pubitemid 44267026)
13. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interestitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009;136:1341-7.
14. Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia. Idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167:1410-15. (Pubitemid 36609727)
15. Song JW, Do K-H, Kim M-Y, et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136:23-30.
16. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770-7. (Pubitemid 15066866)
17. Schneider F, Hwang D, Gibson K, et al. Nonspecific Interstitial Pneumonia: a study of 6 patients with progressive disease. Am J Surg Pathol 2012;36:89-93.
18. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001;164:1722-7. (Pubitemid 33124165)
19. Koreeda Y, Higashimoto I, Yamamoto M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010;49:361-9.
20. Ohosone Y, Ishida M, Takahashi Y, et al. Spectrum and clinical significance of autoantibodies against transfer RNA. Arthritis Rheum 1998;41:1625-31. (Pubitemid 28459921)
21. McBurney C, Aggarwal R, Gibson K, et al. Myositis-associated usual interstitial pneumonia has better survival than idiopathic pulmonary fibrosis. Arthritis Rheum 2012;64:S93.
22. Watanabe K, Handa T, Tanizawa K, et al. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 2011;105:1238-47.
23. Tomioka H, Kaneko M, Kogata Y, et al. A case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis. Respir Investig 2012;50:66-9.
24. Hara Y, Tanaka T, Tabata K, et al. Anti-glycyl tRNA synthetase antibody associated interstitial lung disease without symptoms of polymyositis/ dermatomyositis. Pathology Int 2014;64:148-50.
25. Sauter JL, Butnor KJ. Expanding the spectrum of pulmonary histopathologic manifestations of anti-synthetase syndrome: anti-EJ-associated acute fibrinous and organizing pneumonia. Histopathology 2014. doi:10.1111/his.12420